High blood pressure

2023 was filled with emotions as we said goodbye to many notable faces. From Friends star Matthew Perry's sudden death to Dixie Chicks' Laura Lynch's tragic car crash, fans across the world were left shocked after their favourite star's deaths. However, their legacies continue as they live on forever in the hearts of those who love them. Here's a list of this year's most shocking celebrity deaths: Matthew Perry, Lisa Marie Presley, Angus Cloud, and Tina Turner died in 2023 Laura Lynch Wrap up the year gone by…

According to new research published today in European Heart Journal - Digital Health, a journal of the European Society of Cardiology (ESC), talking on a cell phone for 30 minutes or more per week is associated with a 12pc increased risk of high blood pressure compared to less than 30 minutes. "It's the number of minutes people spend talking on a mobile that matter for heart health, with more minutes meaning greater risk," said study author Professor Xianhui Qin of Southern Medical University, Guangzhou, China. "Years of…

A new study has revealed that the noises around traffic, horns, and engine volume can be linked to increased…

High blood pressure, or hypertension, is one of the most common conditions in the general population, particularly in those who are middle aged and older. It also seemed to be one of the most common conditions among COVID patients, especially those who were hospitalised or died. In a new study, we’ve found that people with high blood pressure have a 22% higher risk of being hospitalised or dying from the virus compared to people without high blood pressure.…

A Medtronic PLC medical device reduced the blood pressure of people with tough-to-treat hypertension in a closely watched study, but not significantly beyond what medications achieved.The device cut a crucial measure of blood pressure by only about two points more than the average reduction in study volunteers who didn’t get the procedure, researchers said Monday. Despite falling short of the study’s main efficacy goal, Medtronic said it has completed its application to the Food and Drug…

The once lucrative heart-drug market is now poised to make a comeback, but at the cost of heavy investments in research and deal making.After watching lower-priced generics seize sales of once-highflying blood-pressure, cholesterol and other heart drugs, companies struggled to discover replacements and then win reimbursement for five-figure prices. Drugmakers are now rolling out new medicines, though their commercial prospects are uncertain. Novartis AG recently launched a new…

…